Metropolis Healthcare Limited Stock price

Equities

METROPOLIS

INE112L01020

Healthcare Facilities & Services

End-of-day quote NSE India S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
1,724 INR -0.31% Intraday chart for Metropolis Healthcare Limited +5.92% +2.71%
Sales 2024 * 11.91B 143M Sales 2025 * 13.56B 163M Capitalization 88.29B 1.06B
Net income 2024 * 1.36B 16.27M Net income 2025 * 1.83B 21.96M EV / Sales 2024 * 7.29 x
Net cash position 2024 * 1.45B 17.43M Net cash position 2025 * 2.87B 34.4M EV / Sales 2025 * 6.3 x
P/E ratio 2024 *
64.3 x
P/E ratio 2025 *
48.2 x
Employees 4,300
Yield 2024 *
0.56%
Yield 2025 *
0.74%
Free-Float 50.26%
More Fundamentals * Assessed data
Dynamic Chart
Metropolis Healthcare's Consolidated Net Profit Declines in Fiscal Q3 MT
Transcript : Metropolis Healthcare Limited, Q3 2024 Earnings Call, Feb 05, 2024
Metropolis Healthcare Limited Announces Management Changes CI
Metropolis Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests RE
Transcript : Metropolis Healthcare Limited, Q2 2024 Earnings Call, Nov 06, 2023
Metropolis Healthcare Limited Approves and Declares Payment of an Interim Dividend for the Financial Year 2023-24 CI
Crisil Keeps AA- Rating on Metropolis Healthcare's Bank Loans; Revises Outlook to Stable MT
Metropolis Healthcare Limited Announces the Cessation of Milind Sarwate as an Independent Director, Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee, Effective September 06, 2023 CI
Metropolis Healthcare Limited Appoints Mohan Menon as Chief Marketing Officer CI
Metropolis Healthcare's Consolidated Profit Drops in Fiscal Q1 MT
Metropolis Healthcare to Seek Smaller Bolt-On Acquisitions CI
Transcript : Metropolis Healthcare Limited, Q1 2024 Earnings Call, Aug 03, 2023
Metropolis Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Metropolis Healthcare Limited Appoints Neha Shah as Interim Company Secretary CI
More news
1 day-0.31%
1 week+5.92%
Current month+7.60%
1 month+7.36%
3 months+3.32%
6 months+22.78%
Current year+2.71%
More quotes
1 week
1 585.00
Extreme 1585
1 814.75
1 month
1 551.05
Extreme 1551.05
1 814.75
Current year
1 450.00
Extreme 1450
1 830.90
1 year
1 171.35
Extreme 1171.35
1 830.90
3 years
1 171.35
Extreme 1171.35
3 579.90
5 years
907.00
Extreme 907
3 579.90
10 years
907.00
Extreme 907
3 579.90
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-01-01
Director of Finance/CFO - 19-11-10
President - 87-06-30
Members of the board TitleAgeSince
Director/Board Member 68 20-05-13
Director/Board Member 44 07-12-31
Director/Board Member 57 17-12-31
More insiders
Date Price Change Volume
24-03-28 1,724 -0.31% 1,235,401
24-03-27 1,729 +4.52% 454,748
24-03-26 1,654 +3.26% 454,541
24-03-22 1,602 -1.55% 208,142
24-03-21 1,627 +0.63% 162,616

End-of-day quote NSE India S.E., March 27, 2024

More quotes
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
1,724 INR
Average target price
1,669 INR
Spread / Average Target
-3.19%
Consensus
  1. Stock
  2. Equities
  3. Stock Metropolis Healthcare Limited - NSE India S.E.